Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.Unknown journal · 2025-04-30630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-08Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label TrialAmerican Journal of Psychiatry · 2024-12-31Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine useFrontiers in Psychiatry · 2024-12-05Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.Unknown journal · 2024-05-08Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trialScientific Reports · 2024-04-16Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment DevelopmentPsychedelic Medicine · 2023-09-05Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.Expert Opinion on Drug Discovery · 2022-08-21Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.ACS Pharmacology & Translational Science · 2021-03-17Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancerJournal of Psychopharmacology · 2020-01-08Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-04Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.Frontiers in Pharmacology · 2018-04-02Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related DistressJournal of Humanistic Psychology · 2017-06-13Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological AnalysisJournal of Humanistic Psychology · 2017-04-27Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of Psychopharmacology · 2016-11-30